2336 Novel PGF2a synthesis pathway in epithelial ovarian cancer

2336 Novel PGF2a synthesis pathway in epithelial ovarian cancer

OBJECTIVES/SPECIFIC AIMS: To understand the role of PGF2a and to characterize a novel cyclooxyrgenase (COX)-independent prostaglandin synthesis pathway in epithelial ovarian cancer. METHODS/STUDY POPULATION: We used high grade epithelial ovarian cancer cell line (OVCAR3) as a model to study our path...

Full description

Bibliographic Details
Main Authors:	Muhan Hu, Ekta Tiwary, Rebecca Arend, Michael Miller
Format:	Article
Language:	English
Published:	Cambridge University Press 2018-06-01
Series:	Journal of Clinical and Translational Science
Online Access:	https://www.cambridge.org/core/product/identifier/S2059866118001036/type/journal_article

Similar Items

Sperm-Guiding Unconventional Prostaglandins in <i>C. elegans</i>: Synthesis and Signaling
by: Ekta Tiwary, et al.
Published: (2021-12-01)

Identification and initial characterization of Hfq-associated sRNAs in Histophilus somni strain 2336
by: Bindu Subhadra, et al.
Published: (2023-01-01)

Identification and initial characterization of Hfq-associated sRNAs in Histophilus somni strain 2336.
by: Bindu Subhadra, et al.
Published: (2023-01-01)

Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian Cancer
by: Brandon M. Roane, et al.
Published: (2019-05-01)

Targeting Signaling Pathways in Epithelial Ovarian Cancer
by: Johannes Haybaeck, et al.
Published: (2013-05-01)

PB2336: TREATMENT PATTERN AND OUTCOME IN SYSTEMIC T AND NK CELL LYMPHOMA: AN ASIAN SINGLE CENTER EXPERIENCE
by: Meng-Ta Sung, et al.
Published: (2023-08-01)

Ubiquitin Proteasome Pathway Transcriptome in Epithelial Ovarian Cancer
by: Jerry Vriend, et al.
Published: (2021-05-01)

Disparity in the era of personalized medicine for epithelial ovarian cancer
by: Michael-John Devlin, et al.
Published: (2023-01-01)

Discovery and Validation of Novel Biomarkers for Detection of Epithelial Ovarian Cancer
by: Hagen Kulbe, et al.
Published: (2019-07-01)

Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
by: Yi Hu, et al.
Published: (2023-01-01)

The effects of PGF2α and CIDR on ovarian antral follicular development and plasma IGF-1 concentration in goats.
by: Bukar, Muhammad Modu, et al.
Published: (2011)

PB2336: BURDEN OF HOSPITALIZATION, COSTS AND CO-MORBIDITIES IN MEDICAID PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): ANALYSIS OF NATIONAL IN-PATIENT HOSPITAL DATABASE
by: S. Aggarwal, et al.
Published: (2022-06-01)

Ovarian follicular changes and hemodynamics in Egyptian buffaloes under CIDR-PGF2α and Ovsynch-CIDR estrus synchronization treatments
by: Haney SAMIR, et al.
Published: (2019-08-01)

The role of pemetrexed in recurrent epithelial ovarian cancer: a scoping review
by: Michael Roche, et al.
Published: (2018-03-01)

PGF2α induces a pro-labour phenotypical switch in human myometrial cells that can be inhibited with PGF2α receptor antagonists
by: Isabel Hamshaw, et al.
Published: (2023-12-01)

Role of lymphangiogenesis in epithelial ovarian cancer.
by: Sundar, S, et al.
Published: (2006)

Immunotherapy Advances for Epithelial Ovarian Cancer
by: Erin G. Hartnett, et al.
Published: (2020-12-01)

The BRCA Gene in Epithelial Ovarian Cancer
by: Luisa Sánchez-Lorenzo, et al.
Published: (2022-02-01)

Targeted Therapies in Epithelial Ovarian Cancer
by: Jurjees Hasan, et al.
Published: (2010-02-01)

EPITHELIAL OVARIAN CANCER. CLINICAL LECTURE
by: A. E. Solopova, et al.
Published: (2016-10-01)

Epithelial ovarian cancer: Review article
by: Suchetha Sambasivan
Published: (2022-01-01)

PENGARUH PGF2A TERHADAP KELAHIRAN DINI KAMBING
by: Perpustakaan UGM, i-lib
Published: (1994)

Gut microbiota dysbiosis promotes the development of epithelial ovarian cancer via regulating Hedgehog signaling pathway
by: Xinyue Hu, et al.
Published: (2023-12-01)

Novel Molecular Targets for Tumor-Specific Imaging of Epithelial Ovarian Cancer Metastases
by: Lysanne D. A. N. de Muynck, et al.
Published: (2020-06-01)

Associations of novel serum lipid index with epithelial ovarian cancer chemoresistance and prognosis
by: Yuan Li, et al.
Published: (2023-02-01)

Effect of Sex Steroids and PGF<sub>2α</sub> on the Expression of Their Receptors and Decorin in Bovine Caruncular Epithelial Cells in Early–Mid Pregnancy
by: Monika Jamioł, et al.
Published: (2022-11-01)

Effects of Estrous Synchronization of Bali Cattle Using PGF2a
by: PN, Indira, et al.
Published: (2014)

SYNCHRONIZATION OF ESTRUS WITH PGF ANALOGUE IN EWES AND GOATS DURING TWO SEASONS
by: AL-SAADI, H.A.K, et al.
Published: (1989-12-01)

The epidemiology of epithelial ovarian cancer: a review
by: Banks, E, et al.
Published: (1997)

Multiple births and risk of epithelial ovarian cancer.
by: Whiteman, D, et al.
Published: (2000)

Angiogenesis inhibitors for the treatment of epithelial ovarian cancer
by: Gaitskell, K, et al.
Published: (2023)

Epithelial Ovarian Cancer—Varied Treatment Results
by: Sonja Millert-Kalińska, et al.
Published: (2023-07-01)

Tumor metabolism rewiring in epithelial ovarian cancer
by: Ming Wang, et al.
Published: (2023-06-01)

Potential of osteopontin in the management of epithelial ovarian cancer
by: Cerne Katarina, et al.
Published: (2019-01-01)

Optimal cytoreduction for advanced epithelial ovarian cancer
by: N. G. Kormosh, et al.
Published: (2014-08-01)

Claudin-4 localization in epithelial ovarian cancer
by: Margaret C. Neville, et al.
Published: (2022-10-01)

The detection, treatment, and biology of epithelial ovarian cancer
by: Gubbels Jennifer AA, et al.
Published: (2010-03-01)

Clinical epidemiology of epithelial ovarian cancer in the UK
by: Doufekas K, et al.
Published: (2014-05-01)

Prognostic biomarker MCP-4 triggers epithelial-mesenchymal transition via the p38 MAPK pathway in ovarian cancer
by: Siting Li, et al.
Published: (2022-12-01)

The Influence of the Interval between Administration of PGF2α, in the Pre-Synchronization Treatments (2xPGF2α), in the Ovsynch Synchronization Program of the Oestrus and the Ovulations in Dairy Cows
by: Nicolae Păcala, et al.
Published: (2023-09-01)